Cover Image
市場調查報告書

全球子宮頸癌診斷檢驗市場

Global Cervical Cancer Diagnostic Tests Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 321448
出版日期 內容資訊 英文 103 Pages
訂單完成後即時交付
價格
Back to Top
全球子宮頸癌診斷檢驗市場 Global Cervical Cancer Diagnostic Tests Market 2014-2018
出版日期: 2014年12月17日 內容資訊: 英文 103 Pages
簡介

子宮頸癌診斷檢驗是為了確定女性的子宮頸部的癌前期病變病變或癌症病變的存在所採用。初期的細胞診斷與HPV檢驗出現陽性的話,為了確定檢查便會進行陰道鏡和抹片檢查,若結果是陽性,會再加上影像檢查決定癌症的惡性程度。全球子宮頸癌診斷檢驗市場2013∼2018年預期以年複合成長率10.89%擴大。

本報告提供全球子宮頸癌診斷檢驗市場現狀與今後的預測、市場規模、各市場區隔的銷售趨勢、各地區趨勢、主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 簡稱說明

第3章 本報告的範圍

第4章 市場調查方法

第5章 簡介

第6章 疾病範例

  • 流行病學
  • 子宮頸癌的原因
  • 子宮頸癌的診斷

第7章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第8章 各檢查市場區隔

  • 細胞診斷
  • HPV檢驗
  • 陰道鏡檢查
  • 子宮頸癌切片檢查
  • 各檢查市場區隔
  • 全球HPV檢驗市場
  • 全球陰道鏡檢查市場
  • 全球細胞診斷市場
  • 全球子宮頸癌切片檢查市場

第9章 各技術市場區隔

第10章 各手法市場區隔

第11章 各地區市場區隔

  • 各地區市場區隔
  • 南北美洲
  • EMEA
  • 亞太地區

第12章 購買標準

第13章 市場成長的促進要素

第14章 促進要素與其影響

第15章 市場課題

第16章 推動市場的要素與課題的影響

第17章 市場趨勢

第18章 趨勢與其影響

第19章 供應商環境

  • 競爭模式
  • 市場佔有率分析
  • 其他值得注意的供應商

第20章 主要供應商分析

  • Abbott Laboratories
  • Becton, Dickinson and Co.
  • Hologic Inc.
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics

第21章 本系列的其他報告

圖表

目錄
Product Code: IRTNTR4839

About Cervical Cancer Diagnostic Tests

Cervical cancer diagnostic tests are used to identify the presence of the precancerous or cancerous lesions in the cervix of a woman. These tests include an initial screening using pap smear and HPV testing, and upon positive results, colposcopy and biopsy are further utilized to confirm the diagnosis. After the positive diagnosis, the patient is further subjected to imaging tests that are used to establish the grade of cancer.

TechNavio's analysts forecast the Global Cervical Cancer Diagnostic Tests market to grow at a CAGR of 10.89 percent over the period 2013-2018.

Covered in this Report

The report covers the present scenario and the growth prospects of the Global Cervical Cancer Diagnostic Tests market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following diagnostic test kits and instruments used to diagnose cervical cancer:

  • Pap Smear Test
  • HPV Testing
  • Colposcopy
  • Biopsy

In addition, the report includes the type of method used to identify cervical cancer:

  • Molecular method
  • Cytopathological method
  • Physical method

Technological types used in cervical cancer identification are also discussed in this report:

  • ELISA
  • FISH
  • NASBA
  • PCR
  • Staining & Microscopy
  • Optical Imaging

TechNavio's report, the Global Cervical Cancer Diagnostic Tests Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Cervical Cancer Diagnostic Tests market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Becton Dickinson
  • Hologic
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics

Other Prominent Vendors

  • Anthera Pharmaceuticals
  • Arbor Vita
  • Autogenomics
  • Biolight Meditech
  • BioMerieux
  • Biovantra
  • Cancer Genetics
  • Cervia Diagnostics
  • Centrel
  • Cooper Surgical
  • Cytoimmun
  • DySIS Medical
  • Edan
  • Femasys
  • Greiner Bio One
  • Guided Therapeutics
  • Incell dx
  • Innogenetics
  • Kernel Medical
  • Lutech Industries
  • Medgyn
  • Micromedic Technologies
  • Norchip
  • Olympus Medical
  • OncoHealth Corp
  • Optomic
  • Optopol Technology
  • Shenzhen Goldcare Meditech
  • Sunray
  • Zilico

Market Driver

  • Increased Incidence of Smoking
  • For a full, detailed list, view our report

Market Challenge

  • Lack of Awareness
  • For a full, detailed list, view our report

Market Trend

  • Development of New Diagnostic Platforms
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Disease Paradigm

  • 06.1. Epidemiology
  • 06.2. Causes of Cervical Cancer
  • 06.3. Diagnosis of Cervical Cancer

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by Type of Test

  • 08.1. Pap Smear Test
    • 08.1.1. Conventional Pap
    • 08.1.2. Liquid-based cytology
  • 08.2. HPV Testing
  • 08.3. Colposcopy
  • 08.4. Cervical Cancer Biopsy
    • 08.4.1. LEEP
    • 08.4.2. ECC
    • 08.4.3. Cone Biopsy
  • 08.5. Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test
  • 08.6. Global HPV Testing Market
    • 08.6.1. Market Size and Forecast
  • 08.7. Global Colposcopy Market
    • 08.7.1. Market Size and Forecast
  • 08.8. Global Pap Smear Test Market
    • 08.8.1. Market Size and Forecast
  • 08.9. Global Cervical Cancer Biopsy Market
    • 08.9.1. Market Size and Forecast

09. Market Segmentation by Technology

  • 09.1. ELISA
  • 09.2. FISH
  • 09.3. NASBA
  • 09.4. PCR
  • 09.5. Multichromatic Staining and Microscopy
  • 09.6. Optical Imaging

10. Market Segmentation by Method

  • 10.1. Molecular Method
  • 10.2. Cytopathological Method
  • 10.3. Physical Method

11. Geographical Segmentation

  • 11.1. Geographical Segmentation of Global Cervical Cancer Diagnostic Tests Market
  • 11.2. Cervical Cancer Diagnostic Tests Market in Americas
    • 11.2.1. Market Size and Forecast
  • 11.3. Cervical Cancer Diagnostic Tests Market in EMEA Region
    • 11.3.1. Market Size and Forecast
  • 11.4. Cervical Cancer Diagnostic Tests Market in APAC Region
    • 11.4.1. Market Size and Forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Market Share Analysis 2013
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Abbott Laboratories
    • 20.1.1. Key Facts
    • 20.1.2. Business Overview
    • 20.1.3. Business Segmentation by Revenue
    • 20.1.4. Business Segmentation by Revenue 2011 and 2012
    • 20.1.5. Geographical Segmentation by Revenue
    • 20.1.6. Business Strategy
    • 20.1.7. Key Information
    • 20.1.8. SWOT Analysis
  • 20.2. Becton, Dickinson and Co.
    • 20.2.1. Key Facts
    • 20.2.2. Business Description
    • 20.2.3. Business Segmentation
    • 20.2.4. Revenue Segmentation by Business
    • 20.2.5. Segmental Revenue Comparison - 2013 and 2012
    • 20.2.6. Revenue Segmentation by Geography
    • 20.2.7. Business Strategy
    • 20.2.8. Key Developments
    • 20.2.9. SWOT Analysis
  • 20.3. Hologic Inc.
    • 20.3.1. Key Facts
    • 20.3.2. Business Overview
    • 20.3.3. Business Segmentation by Revenue 2013
    • 20.3.4. Business Segmentation by Revenue 2012 and 2013
    • 20.3.5. Sales by Geography
    • 20.3.6. Business Strategy
    • 20.3.7. Key Developments
    • 20.3.8. SWOT Analysis
  • 20.4. Qiagen
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Product Segmentation by Revenue 2013
    • 20.4.4. Product Segmentation by Revenue 2012 and 2013
    • 20.4.5. Geographical Segmentation by Revenue 2013
    • 20.4.6. Business Strategy
    • 20.4.7. Recent Developments
    • 20.4.8. SWOT Analysis
  • 20.5. Quest Diagnostics
    • 20.5.1. Key Facts
    • 20.5.2. Business Overview
    • 20.5.3. Business Segmentation by Revenue 2013
    • 20.5.4. Business Segmentation by Revenue 2011-2013
    • 20.5.5. Geographical Segmentation by Revenue 2013
    • 20.5.6. Business Strategy
    • 20.5.7. Recent Developments
    • 20.5.8. SWOT Analysis
  • 20.6. Roche Diagnostics
    • 20.6.1. Key Facts
    • 20.6.2. Business Overview
    • 20.6.3. Business Segmentation by Revenue 2013
    • 20.6.4. Geographical Segmentation by Revenue 2013
    • 20.6.5. Business Strategy
    • 20.6.6. Recent Developments

21. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Incidence of Cervical Cancer (2013-2018)
  • Exhibit 3: Global Cervical Cancer Diagnostic Tests Market 2013-2018 (US$ million)
  • Exhibit 4: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test
  • Exhibit 5: Segmentation of Cervical Cancer Diagnostic Test Products by Type of Test
  • Exhibit 6: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test 2013-2018 (US$ million)
  • Exhibit 7: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test 2013-2018
  • Exhibit 8: Global HPV Testing Market 2013-2018 (US$ million)
  • Exhibit 9: Global Colposcopy Market 2013-2018 (US$ million)
  • Exhibit 10: Global Pap Smear Test Market 2013-2018 (US$ million)
  • Exhibit 11: Global Cervical Cancer Biopsy Market 2013-2018 (US$ million)
  • Exhibit 12: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Technology
  • Exhibit 13: Cervical Cancer Diagnostic Test Products Segmented by Technology
  • Exhibit 14: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Method
  • Exhibit 15: List of Tests Segmented Based on Methods used in Cervical Cancer Diagnostic Tests
  • Exhibit 16: Geographical Segmentation of Global Cervical Cancer Diagnostic Tests Market 2013-2018 (US$ million)
  • Exhibit 17: Global Cervical Cancer Diagnostic Tests Market by Geographical Segmentation 2013-2018
  • Exhibit 18: Cervical Cancer Diagnostic Tests Market in Americas 2013-2018 (US$ million)
  • Exhibit 19: Cervical Cancer Diagnostic Tests Market in EMEA Region 2013-2018 (US$ million)
  • Exhibit 20: Cervical Cancer Diagnostic Tests Market in APAC Region 2013-2018 (US$ million)
  • Exhibit 21: Advantages and Limitations of Various Diagnostic Platforms
  • Exhibit 22: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 23: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 24: Product Categorization of Becton, Dickinson and Co.
  • Exhibit 25: Revenue Segmentation of Becton, Dickinson and Co. 2013
  • Exhibit 26: Revenue Comparison (US$ million)
  • Exhibit 27: Revenue Segmentation of Becton, Dickinson and Co. by Geography 2013
  • Exhibit 28: Revenue Segmentation of Hologic Inc. 2013
  • Exhibit 29: Revenue Comparison FY2012 and FY2013 (US$ million)
  • Exhibit 30: Hologic Inc.: Sales by Geography 2013
  • Exhibit 31: Qiagen: Product Segmentation by Revenue 2013
  • Exhibit 32: Qiagen: Product Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 33: Qiagen: Geographical Segmentation by Revenue 2013
  • Exhibit 34: Quest Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 35: Quest Diagnostics: Business Segmentation by Revenue 2011-2013 (US$ billion)
  • Exhibit 36: Quest Diagnostics: Geographical Segmentation by Revenue 2013
  • Exhibit 37: Roche Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 38: Roche Diagnostics: Geographical Segmentation by Revenue 2013
Back to Top